Daniel Glenn Gibson - Aug 4, 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role
Chief Technology Officer
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Aug 4, 2022
Transactions value $
$0
Form type
4
Date filed
8/8/2022, 04:04 PM
Previous filing
Mar 1, 2022
Next filing
May 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) Award $0 +100K $0.00 100K Aug 4, 2022 Common Stock 100K $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on August 4, 2024.

Remarks:

Exhibit 24 - Power of Attorney